5-fluoro-3-(1-methyl-3,6-dihydro-2H-pyridin-4-yl)-1-[3-(2-methylpyrimidin-4-yl)phenyl]sulfonylindole
C25H23FN4O2S — CID 24743725
Data last refreshed: (MolForge compound catalog, from PubChem)
About 5-fluoro-3-(1-methyl-3,6-dihydro-2H-pyridin-4-yl)-1-[3-(2-methylpyrimidin-4-yl)phenyl]sulfonylindole
5-fluoro-3-(1-methyl-3,6-dihydro-2H-pyridin-4-yl)-1-[3-(2-methylpyrimidin-4-yl)phenyl]sulfonylindole (PubChem CID 24743725) has the molecular formula C25H23FN4O2S and a molecular weight of 462.55 g/mol. Its IUPAC name is 5-fluoro-3-(1-methyl-3,6-dihydro-2H-pyridin-4-yl)-1-[3-(2-methylpyrimidin-4-yl)phenyl]sulfonylindole.
Molecular Properties
| Compound Name | 5-fluoro-3-(1-methyl-3,6-dihydro-2H-pyridin-4-yl)-1-[3-(2-methylpyrimidin-4-yl)phenyl]sulfonylindole |
|---|---|
| PubChem CID | 24743725 |
| Molecular Formula | C25H23FN4O2S |
| Molecular Weight | 462.55 g/mol |
| Exact Mass | 462.15 |
| IUPAC Name | 5-fluoro-3-(1-methyl-3,6-dihydro-2H-pyridin-4-yl)-1-[3-(2-methylpyrimidin-4-yl)phenyl]sulfonylindole |
| SMILES | Cc1nccc(-c2cccc(S(=O)(=O)n3cc(C4=CCN(C)CC4)c4cc(F)ccc43)c2)n1 |
| InChI | InChI=1S/C25H23FN4O2S/c1-17-27-11-8-24(28-17)19-4-3-5-21(14-19)33(31,32)30-16-23(18-9-12-29(2)13-10-18)22-15-20(26)6-7-25(22)30/h3-9,11,14-16H,10,12-13H2,1-2H3 |
| InChIKey | JZTFQOFQGAMMJA-UHFFFAOYSA-N |
| XLogP | 4.50 |
| TPSA | 68.09 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 4 |
| Heavy Atoms | 33 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 462.55 |
| LogP ≤ 5 | 4.50 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 6 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 24743725 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.